The role of surgery for high-risk prostate cancer

被引:0
|
作者
Ucer, Oktay [1 ]
Muezzinoglu, Talha [1 ]
机构
[1] Celal Bayar Univ, Tip Fak, Urol Anabilim Dali, Manisa, Turkey
来源
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY | 2014年 / 13卷 / 01期
关键词
high-risk prostate cancer; radical prostatectomy; prostate cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Because of PSA screening, urologists can detect clinically localized prostate cancer in patients before the disease has progressed to advanced stages. Nevertheless, some patients are still diagnosed with high-risk prostate cancer. Surgery for high-risk prostate cancer is applied frequently nowadays. Nevertheless, this approach is still surrounded by many controversies. In some high-risk prostate cancer patients, surgery is a one-step modality in treatment and has an excellent oncological prognosis. However, because of the lack of evidence and well-controlled comparative prospective studies, the best course of treatment can be unclear, and oncological outcomes often appear heterogeneous. The aim of this review is to discuss the role of surgery in high risk prostate cancer.
引用
收藏
页码:21 / 24
页数:4
相关论文
共 50 条
  • [21] Radical Prostatectomy as Primary Treatment of High-risk Prostate Cancer
    Ingels, Alexandre
    de la Taille, Alexandre
    Ploussard, Guillaume
    CURRENT UROLOGY REPORTS, 2012, 13 (02) : 179 - 186
  • [22] Radical Prostatectomy as Primary Treatment of High-risk Prostate Cancer
    Alexandre Ingels
    Alexandre de la Taille
    Guillaume Ploussard
    Current Urology Reports, 2012, 13 : 179 - 186
  • [23] The role of surgery in high risk and advanced prostate cancer: A narrative review
    Roy, Chloe Sheila Dayan
    Sachdeva, Ashwin
    Kandaswamy, Gokul Vignesh
    Rai, Bhavan Prasad
    TURKISH JOURNAL OF UROLOGY, 2021, 47 : S56 - S64
  • [24] Multimodal approaches to high-risk prostate cancer
    Koupparis, A.
    Gleave, M. E.
    CURRENT ONCOLOGY, 2010, 17 : S33 - S37
  • [25] Concurrent chemoradiation for high-risk prostate cancer
    Cooper, Benjamin T.
    Sanfilippo, Nicholas J.
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2015, 6 (04): : 35 - 42
  • [26] High-risk prostate cancer. Review
    Rozet, F.
    Hennequin, C.
    Fromont, G.
    Mongiat-Artus, P.
    Bastide, C.
    Beuzeboc, P.
    Cormier, L.
    Eiss, D.
    Peyrornaure, M.
    Richaud, P.
    Salomon, L.
    Soulie, M.
    PROGRES EN UROLOGIE, 2011, 21 (13): : 901 - 908
  • [27] Treatment for intermediate and high-risk prostate cancer: Controversial issues and the role of hyperthermia
    Maluta, Sergio
    Dall'oglio, Stefano
    Nadalini, Luisa
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2010, 26 (08) : 765 - 774
  • [28] Adjuvant Therapy in High-Risk Prostate Cancer
    Shevach, Jeffrey
    Chaudhuri, Parul
    Morgans, Alicia K.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (01) : 45 - 53
  • [29] Approach to the Patient with High-Risk Prostate Cancer
    Mossanen, Matthew
    Krasnow, Ross E.
    Nguyen, Paul L.
    Trinh, Quoc D.
    Preston, Mark
    Kibel, Adam S.
    UROLOGIC CLINICS OF NORTH AMERICA, 2017, 44 (04) : 635 - +
  • [30] Management of High-Risk Localised Prostate Cancer
    Ozen, Haluk
    Yazici, Sertac
    Inci, Kubilay
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (05) : 439 - 447